申请人:BRISTOL-MYERS SQUIBB COMPANY
公开号:US20150133428A1
公开(公告)日:2015-05-14
The invention provides compounds of Formula (I):
and pharmaceutically acceptable salts thereof. The compounds of Formula (I) inhibit protein kinase activity thereby making them useful as anticancer agents.
本发明提供式(I)的化合物及其药学上可接受的盐。式(I)的化合物抑制蛋白激酶活性,因此具有作为抗癌剂的用途。